CXCL8 and hepatocellular carcinoma: Compared to the HCC patients without co-expression of NTS and IL-8, the OS of NTS+IL-8+ HCC patients significantly decreased (24.65±4.45 m vs. 75.79±16.32 m, P = 0.013), and these patients are under a higher hazard of death at an expected hazard ratio (HR) of 3.457.